- Display 15 Products per page
Published: October 2, 2018 | Price: $250.00 – $500.00
Trends in IVD Fall of 2017Published: October 19, 2017 | Price: $200.00 – $400.00
New products in IVD, as launched at major diagnostic conventions.Published: August 15, 2017 | Price: $200.00 – $400.00
Coverage of major IVD industry events and trends July 2017.Published: June 23, 2017 | Price: $400.00 – $800.00
Published: December 17, 2015 | Price: $349.30 – $700.00
Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market examines the urine strip segment of the global POC professional testing and self-testing markets and the urinalysis segment of the POC professional drugs of abuse testing market, including: Selected Dipstick Urinalysis Systems, 2014 Global POC Urine Strip Testing Market Analysis: 2012-2019 POC Urine Strip Self-Testing Market Analysis, 2014 and 2019 POC Urine...Published: November 9, 2015 | Price: $250.00 – $500.00
QIAGEN: Company Profile QIAGEN, a leading global provider of sample and assay technologies, markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). QIAGEN: Company Profile examines the global healthcare company whose sample technologies isolate and process DNA, RNA and proteins from biological samples such as blood...Published: November 2, 2015 | Price: $250.00 – $500.00
Roche Diagnostics: Company Profile Roche Diagnostics: Company Profile examines the Swiss global research-based healthcare company. With product sales almost twice that of its nearest competition, Roche is the world's largest supplier of clinical diagnostics products. Roche is as well the global world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche is also the world's largest biotech company, with 14 biopharmaceuticals on the market. Further, Roche's personalized healthcare strategy aims at providing medicines...Published: October 26, 2015 | Price: $499.00 – $1,000.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market documents some 240 acquisitions that have taken place from 2012 to October 2015 in the extremely dynamic IVD industry. And this is likely only a small portion of what is really happening in the market; more deals are still to come. In vitro diagnostic (IVD) companies have been very busy with respect to acquisitions in an attempt to augment market share in an increasingly competitive market....Published: April 17, 2015 | Price: $499.00 – $1,000.00
The Market for Clinical Chemistry Routine clinical chemistry comprises 30 to 40 tests of substrates, metabolites, electrolytes, blood gases, enzymes and lipids that can be organized into panels for specialty patient investigation and routine patient screening. Common specialty panels include those for renal clearance, liver function, and metabolic status. Clinical chemistries are performed on analyzers with varying levels of automation depending on the test volume run at a particular test site. The market for routine clinical chemistries can be segmented...Published: January 21, 2015 | Price: $500.00 – $1,000.00
Siemens Healthcare: Company Profile Siemens Healthcare: Company Profile opens with a discussion of top IVD suppliers, market trends, and general size and growth of the IVD market. Kalorama Information's report then focuses on a key company in the in vitro diagnostics (IVD) industry: Siemens Healthcare. Siemens Healthcare offers a comprehensive portfolio of medical solutions across the treatment chain – from prevention and early detection to diagnosis, treatment and follow-up care. Siemens is a major supplier of technology to the healthcare...Published: January 21, 2015 | Price: $500.00 – $1,000.00
Roche Diagnostics: Company Profile Roche Diagnostics: Company Profile opens with a discussion of top IVD suppliers, market trends, and general size and growth of the IVD market. Kalorama Information's report then focuses on a key company in the in vitro diagnostics (IVD) industry: Roche Diagnostics. Roche is the world's largest supplier of clinical diagnostics products, the world leader in IVD and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic...Published: January 12, 2015 | Price: $500.00 – $1,000.00
Abbott Diagnostics: Company Profile Abbott Diagnostics: Company Profile opens with a discussion of top IVD suppliers, market trends, and general size and growth of the IVD market. Kalorama Information's report then focuses on a key company in the in vitro diagnostics (IVD) industry: Abbott Diagnostics. Abbott Laboratories is a global leader in the IVD industry, a global, diversified health care company active in pharmaceuticals, nutritionals, devices and diagnostics. Abbott's diagnostic products’ strength lies in their sheer presence worldwide. The company...Published: June 1, 2012 | Price: $495.00 – $990.00
In February and March of 2012, Kalorama Information conducted a survey of 2,000 adults to ask them whether or not they would take a genetic test. This report, Consumer Testing and the Future of DTC Genetic Testing provides those results and compiles surveys from public and private sources to provide the following insights: Have Consumers Used a Self-Test Product? Would They Take a Genetic Test? Are They Concerned About Their Healthcare? What Diseases Are They Most Concerned About?...Published: May 1, 2009 | Price: $250.00 – $1,600.00
The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The...Published: May 1, 2009 | Price: $250.00 – $3,395.00
It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information's lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen's new report In Vitro Diagnostics in a Recessionary Economy. The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro...